J&J expands deal with little-known Welsh biotech using 3D printing to better encapsulate drugs
J&J is doubling back to a small partner after its original collaboration agreement proved a success.
The company is teaming up again with Welsh biotech Midatech Pharma on a second compound, Midatech announced Wednesday, with a focus on developing a large molecule drug. No financials were disclosed in the announcement, but Midatech noted the J&J collaboration first got underway about two years ago.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.